Bibliographic citations
Chapoñan, A., Miguel, A., Díaz, G., Gonzales, M., Hernandez, K. (2023). Reactivación de Herpes zóster en población vacunada por COVID 19: Una revisión narrativa [Trabajo de investigación, Universidad Peruana de Ciencias Aplicadas (UPC)]. http://hdl.handle.net/10757/667339
Chapoñan, A., Miguel, A., Díaz, G., Gonzales, M., Hernandez, K. Reactivación de Herpes zóster en población vacunada por COVID 19: Una revisión narrativa [Trabajo de investigación]. PE: Universidad Peruana de Ciencias Aplicadas (UPC); 2023. http://hdl.handle.net/10757/667339
@misc{renati/404213,
title = "Reactivación de Herpes zóster en población vacunada por COVID 19: Una revisión narrativa",
author = "Hernandez Randich, Karla Lorena",
publisher = "Universidad Peruana de Ciencias Aplicadas (UPC)",
year = "2023"
}
This review describes the current evidence on the reported relationship between the application of the COVID-19 vaccine and the reactivation of the Herpes zoster virus. Reports of cases published in the bibliographic databases of Pubmed, Scopus, Web of Science and Google Scholar from 2020 to 2021 were reviewed. The findings were divided into the following sections: Epidemiological data, associated COVID-19 vaccines, clinical manifestations, laboratory, comorbidities or history of immunosuppression, degree of disease, complications, infection and previous vaccination against varicella; and finally management and treatment. The bibliographic review includes 15 case report-type articles, finding a total of 52 patients affected after receiving the COVID-19 vaccine, being the Pfizer, Modern vaccines the most reported, being the male sex the predominant one and thoracic dermatomes and lumbar the most affected areas. Cases of shingles associated with COVID-19 vaccines have been reported around the world. Although pathophysiological mechanisms are postulated that could explain this association, more studies still need to be carried out to confirm it.
This item is licensed under a Creative Commons License